JUN and adenocarcinoma: While the published studies on c-Jun have not explored the correlations with pathological stages in adenocarcinoma [34], we have shown the higher p-c-Jun expression in adenomas and HGINs than in adenocarcinomas, and its negative correlation with pT stage progression in invasive cacinomas.